Trial Profile
THE BALANCE Study: Treatment of Hyponatraemia Based on Lixivaptan in NYHA Class III/IV Cardiac Patient Evaluation
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 24 Aug 2016
Price :
$35
*
At a glance
- Drugs Lixivaptan (Primary)
- Indications Hyponatraemia
- Focus Registrational; Therapeutic Use
- Acronyms BALANCE
- Sponsors Cardiokine
- 09 Aug 2014 New trial record
- 24 Nov 2010
- 24 Mar 2010